|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
0.01%
|
US
|
NASDAQ
|
|
KIDS
|
OrthoPediatrics Corp.
|
0.01%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
INGN
|
Inogen, Inc
|
0.01%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IMGO
|
Imago BioSciences, Inc
|
0.01%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
HSTM
|
HealthStream, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
HSKA
|
Heska Corporation
|
0.01%
|
US
|
NASDAQ
|
|
HIMS
|
Hims & Hers Health, Inc.
|
0.01%
|
US
|
NYSE
|
|
HCAT
|
Health Catalyst, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
GDRX
|
GoodRx Holdings, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
FIGS
|
FIGS, Inc.
|
0.01%
|
US
|
NYSE
|
|
EQRX
|
EQRx, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|